HEADER OXIDOREDUCTASE 09-MAY-22 7ZT0 TITLE CRYSTAL STRUCTURE OF CYP125 FROM MYCOBACTERIUM TUBERCULOSIS IN COMPLEX TITLE 2 WITH AN INHIBITOR COMPND MOL_ID: 1; COMPND 2 MOLECULE: STEROID C26-MONOOXYGENASE; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: CHOLEST-4-EN-3-ONE 26-MONOOXYGENASE,CHOLEST-4-EN-3-ONE C26- COMPND 5 MONOOXYGENASE [(25S)-3-OXOCHOLEST-4-EN-26-OATE FORMING],CHOLESTEROL COMPND 6 C26-MONOOXYGENASE,CHOLESTEROL C26-MONOOXYGENASE [(25S)-3BETA- COMPND 7 HYDROXYCHOLEST-5-EN-26-OATE FORMING],CYTOCHROME P450 125,STEROID C27- COMPND 8 MONOOXYGENASE; COMPND 9 EC: 1.14.15.29; COMPND 10 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: MYCOBACTERIUM TUBERCULOSIS H37RV; SOURCE 3 ORGANISM_TAXID: 83332; SOURCE 4 ATCC: 25618; SOURCE 5 GENE: CYP125, CYP125A1, RV3545C, MTCY03C7.11; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 7 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 8 EXPRESSION_SYSTEM_VARIANT: C41; SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PET21A KEYWDS CYP, P450, CYTOCHROME, CYP125, CHOLESTEROL, TUBERCULOSIS, KEYWDS 2 MYCOBACTERIUM, INHIBITOR, MONOOXYGENASE, OXIDOREDUCTASE EXPDTA X-RAY DIFFRACTION AUTHOR M.SNEE,M.KATARIYA,C.LEVY,D.LEYS REVDAT 3 07-FEB-24 7ZT0 1 REMARK REVDAT 2 31-MAY-23 7ZT0 1 JRNL REVDAT 1 05-APR-23 7ZT0 0 JRNL AUTH M.M.KATARIYA,M.SNEE,R.B.TUNNICLIFFE,M.E.KAVANAGH, JRNL AUTH 2 H.I.M.BOSHOFF,C.N.AMADI,C.W.LEVY,A.W.MUNRO,C.ABELL,D.LEYS, JRNL AUTH 3 A.G.COYNE,K.J.MCLEAN JRNL TITL STRUCTURE BASED DISCOVERY OF INHIBITORS OF CYP125 AND CYP142 JRNL TITL 2 FROM MYCOBACTERIUM TUBERCULOSIS. JRNL REF CHEMISTRY V. 29 03868 2023 JRNL REFN ISSN 0947-6539 JRNL PMID 36912255 JRNL DOI 10.1002/CHEM.202203868 REMARK 2 REMARK 2 RESOLUTION. 1.99 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX 1.20.1_4487 REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : GEOSTD + MONOMER LIBRARY + CDL V1.2 REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.99 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 76.44 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.330 REMARK 3 COMPLETENESS FOR RANGE (%) : 100.0 REMARK 3 NUMBER OF REFLECTIONS : 64981 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.206 REMARK 3 R VALUE (WORKING SET) : 0.205 REMARK 3 FREE R VALUE : 0.237 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.960 REMARK 3 FREE R VALUE TEST SET COUNT : 3221 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 76.4400 - 5.6600 1.00 2889 149 0.1736 0.1939 REMARK 3 2 5.6600 - 4.4900 1.00 2786 130 0.1595 0.1999 REMARK 3 3 4.4900 - 3.9200 1.00 2713 166 0.1584 0.1835 REMARK 3 4 3.9200 - 3.5700 1.00 2688 171 0.1831 0.2211 REMARK 3 5 3.5700 - 3.3100 1.00 2716 145 0.2003 0.2579 REMARK 3 6 3.3100 - 3.1100 1.00 2686 130 0.2320 0.2781 REMARK 3 7 3.1100 - 2.9600 1.00 2704 116 0.2288 0.2756 REMARK 3 8 2.9600 - 2.8300 1.00 2681 143 0.2375 0.2772 REMARK 3 9 2.8300 - 2.7200 1.00 2677 148 0.2604 0.2459 REMARK 3 10 2.7200 - 2.6300 1.00 2669 143 0.2467 0.2913 REMARK 3 11 2.6300 - 2.5400 1.00 2689 140 0.2394 0.2365 REMARK 3 12 2.5400 - 2.4700 1.00 2672 132 0.2236 0.2217 REMARK 3 13 2.4700 - 2.4100 1.00 2651 146 0.2310 0.2630 REMARK 3 14 2.4100 - 2.3500 1.00 2646 128 0.2426 0.2621 REMARK 3 15 2.3500 - 2.2900 1.00 2687 139 0.2360 0.2558 REMARK 3 16 2.2900 - 2.2500 1.00 2656 136 0.2495 0.3007 REMARK 3 17 2.2500 - 2.2000 1.00 2643 149 0.2513 0.3515 REMARK 3 18 2.2000 - 2.1600 1.00 2666 122 0.2726 0.2793 REMARK 3 19 2.1600 - 2.1200 1.00 2627 161 0.2754 0.3130 REMARK 3 20 2.1200 - 2.0800 1.00 2687 114 0.2883 0.3404 REMARK 3 21 2.0800 - 2.0500 1.00 2630 124 0.2850 0.3026 REMARK 3 22 2.0500 - 2.0200 1.00 2662 144 0.3051 0.3181 REMARK 3 23 2.0200 - 1.9900 1.00 2635 145 0.3156 0.3403 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.10 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.256 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 26.383 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 43.50 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 52.62 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.003 6871 REMARK 3 ANGLE : 0.633 9371 REMARK 3 CHIRALITY : 0.041 953 REMARK 3 PLANARITY : 0.005 1239 REMARK 3 DIHEDRAL : 9.515 950 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 1 REMARK 3 TLS GROUP : 1 REMARK 3 SELECTION: ALL REMARK 3 ORIGIN FOR THE GROUP (A): -15.8226 -10.2372 18.7437 REMARK 3 T TENSOR REMARK 3 T11: 0.3265 T22: 0.3154 REMARK 3 T33: 0.3782 T12: 0.0169 REMARK 3 T13: -0.0121 T23: -0.0279 REMARK 3 L TENSOR REMARK 3 L11: 0.6816 L22: 0.5568 REMARK 3 L33: 1.4295 L12: 0.0737 REMARK 3 L13: 0.5901 L23: 0.3946 REMARK 3 S TENSOR REMARK 3 S11: -0.0471 S12: -0.0370 S13: 0.0670 REMARK 3 S21: 0.0266 S22: -0.0288 S23: 0.0129 REMARK 3 S31: -0.1639 S32: -0.0963 S33: 0.0685 REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 7ZT0 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 09-MAY-22. REMARK 100 THE DEPOSITION ID IS D_1292122891. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 08-JUL-19 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 6.2 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : DIAMOND REMARK 200 BEAMLINE : I04-1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.9159 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS 6M-F REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XIA2 REMARK 200 DATA SCALING SOFTWARE : AIMLESS REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 65089 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.990 REMARK 200 RESOLUTION RANGE LOW (A) : 90.100 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 100.0 REMARK 200 DATA REDUNDANCY : 6.600 REMARK 200 R MERGE (I) : 0.07100 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 11.4000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.99 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.04 REMARK 200 COMPLETENESS FOR SHELL (%) : 100.0 REMARK 200 DATA REDUNDANCY IN SHELL : 6.80 REMARK 200 R MERGE FOR SHELL (I) : 1.47400 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 1.100 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: 2XN8 REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 50.84 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.50 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.1M MES PH 6.2, 1.9M AMMONIUM REMARK 280 SULPHATE, VAPOR DIFFUSION, TEMPERATURE 277.15K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 33.90400 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 76.43650 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 45.04800 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 76.43650 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 33.90400 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 45.04800 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 ASN A 16 REMARK 465 GLY A 17 REMARK 465 PRO A 18 REMARK 465 ARG A 428 REMARK 465 CYS A 429 REMARK 465 PRO A 430 REMARK 465 VAL A 431 REMARK 465 ALA A 432 REMARK 465 HIS A 433 REMARK 465 ASN B 16 REMARK 465 GLY B 17 REMARK 465 PRO B 18 REMARK 465 ARG B 428 REMARK 465 CYS B 429 REMARK 465 PRO B 430 REMARK 465 VAL B 431 REMARK 465 ALA B 432 REMARK 465 HIS B 433 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 LYS A 226 CG CD CE NZ REMARK 470 GLU A 230 CG CD OE1 OE2 REMARK 470 LYS A 233 CG CD CE NZ REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 OE2 GLU B 204 O HOH B 601 2.06 REMARK 500 O1A HEM A 501 O HOH A 601 2.14 REMARK 500 OE1 GLU B 408 O HOH B 602 2.18 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ALA A 50 74.29 -160.64 REMARK 500 HIS A 85 59.76 -98.17 REMARK 500 ASP A 247 -166.31 -78.30 REMARK 500 ASN A 270 -82.84 -108.04 REMARK 500 THR A 311 70.60 29.12 REMARK 500 PRO A 365 45.06 -85.40 REMARK 500 TRP A 414 -22.48 -155.68 REMARK 500 ALA B 50 75.24 -159.60 REMARK 500 HIS B 85 57.76 -100.94 REMARK 500 ASP B 247 -167.31 -78.90 REMARK 500 ASN B 270 -82.71 -103.27 REMARK 500 THR B 311 68.65 25.91 REMARK 500 GLN B 352 -59.94 60.98 REMARK 500 GLN B 352 -59.71 60.77 REMARK 500 ASN B 362 117.64 -160.33 REMARK 500 PRO B 365 39.51 -83.64 REMARK 500 MET B 398 59.68 -142.54 REMARK 500 TRP B 414 -22.03 -148.76 REMARK 500 TRP B 421 104.98 -160.37 REMARK 500 REMARK 500 REMARK: NULL REMARK 620 REMARK 620 METAL COORDINATION REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 HEM A 501 FE REMARK 620 N RES CSSEQI ATOM REMARK 620 1 CYS A 377 SG REMARK 620 2 HEM A 501 NA 98.1 REMARK 620 3 HEM A 501 NB 89.9 89.5 REMARK 620 4 HEM A 501 NC 90.1 171.5 88.2 REMARK 620 5 HEM A 501 ND 97.4 90.9 172.6 90.3 REMARK 620 6 JUR A 502 N12 162.8 65.0 93.0 107.0 80.5 REMARK 620 N 1 2 3 4 5 REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 HEM B 501 FE REMARK 620 N RES CSSEQI ATOM REMARK 620 1 CYS B 377 SG REMARK 620 2 HEM B 501 NA 96.3 REMARK 620 3 HEM B 501 NB 87.3 90.2 REMARK 620 4 HEM B 501 NC 85.4 177.9 88.7 REMARK 620 5 HEM B 501 ND 93.0 89.7 179.7 91.4 REMARK 620 6 JUR B 502 N12 170.7 74.5 92.6 103.9 87.1 REMARK 620 N 1 2 3 4 5 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 7QWN RELATED DB: PDB REMARK 900 7QWN CONTAINS THE SAME PROTEIN IN COMPLEX WITH A DIFFERENT INHIBITOR REMARK 900 RELATED ID: 7QKE RELATED DB: PDB REMARK 900 7QKE CONTAINS A SURFACE-ENTROPY REDUCTION MUTANT OF THE SAME REMARK 900 PROTEIN IN COMPLEX WITH A DIFFERENT INHIBITOR REMARK 900 RELATED ID: 7YXF RELATED DB: PDB REMARK 900 7YXF CONTAINS THE SAME PROTEIN IN COMPLEX WITH A DIFFERENT INHIBITOR REMARK 900 RELATED ID: 7ZQR RELATED DB: PDB REMARK 900 7ZQR CONTAINS THE SAME PROTEIN IN COMPLEX WITH A DIFFERENT INHIBITOR REMARK 900 RELATED ID: 7R1I RELATED DB: PDB REMARK 900 7R1I CONTAINS THE SAME PROTEIN IN COMPLEX WITH A DIFFERENT INHIBITOR DBREF 7ZT0 A 18 433 UNP P9WPP1 CP125_MYCTU 18 433 DBREF 7ZT0 B 18 433 UNP P9WPP1 CP125_MYCTU 18 433 SEQADV 7ZT0 ASN A 16 UNP P9WPP1 EXPRESSION TAG SEQADV 7ZT0 GLY A 17 UNP P9WPP1 EXPRESSION TAG SEQADV 7ZT0 ASN B 16 UNP P9WPP1 EXPRESSION TAG SEQADV 7ZT0 GLY B 17 UNP P9WPP1 EXPRESSION TAG SEQRES 1 A 418 ASN GLY PRO SER PRO ASN LEU PRO PRO GLY PHE ASP PHE SEQRES 2 A 418 THR ASP PRO ALA ILE TYR ALA GLU ARG LEU PRO VAL ALA SEQRES 3 A 418 GLU PHE ALA GLU LEU ARG SER ALA ALA PRO ILE TRP TRP SEQRES 4 A 418 ASN GLY GLN ASP PRO GLY LYS GLY GLY GLY PHE HIS ASP SEQRES 5 A 418 GLY GLY PHE TRP ALA ILE THR LYS LEU ASN ASP VAL LYS SEQRES 6 A 418 GLU ILE SER ARG HIS SER ASP VAL PHE SER SER TYR GLU SEQRES 7 A 418 ASN GLY VAL ILE PRO ARG PHE LYS ASN ASP ILE ALA ARG SEQRES 8 A 418 GLU ASP ILE GLU VAL GLN ARG PHE VAL MET LEU ASN MET SEQRES 9 A 418 ASP ALA PRO HIS HIS THR ARG LEU ARG LYS ILE ILE SER SEQRES 10 A 418 ARG GLY PHE THR PRO ARG ALA VAL GLY ARG LEU HIS ASP SEQRES 11 A 418 GLU LEU GLN GLU ARG ALA GLN LYS ILE ALA ALA GLU ALA SEQRES 12 A 418 ALA ALA ALA GLY SER GLY ASP PHE VAL GLU GLN VAL SER SEQRES 13 A 418 CYS GLU LEU PRO LEU GLN ALA ILE ALA GLY LEU LEU GLY SEQRES 14 A 418 VAL PRO GLN GLU ASP ARG GLY LYS LEU PHE HIS TRP SER SEQRES 15 A 418 ASN GLU MET THR GLY ASN GLU ASP PRO GLU TYR ALA HIS SEQRES 16 A 418 ILE ASP PRO LYS ALA SER SER ALA GLU LEU ILE GLY TYR SEQRES 17 A 418 ALA MET LYS MET ALA GLU GLU LYS ALA LYS ASN PRO ALA SEQRES 18 A 418 ASP ASP ILE VAL THR GLN LEU ILE GLN ALA ASP ILE ASP SEQRES 19 A 418 GLY GLU LYS LEU SER ASP ASP GLU PHE GLY PHE PHE VAL SEQRES 20 A 418 VAL MET LEU ALA VAL ALA GLY ASN GLU THR THR ARG ASN SEQRES 21 A 418 SER ILE THR GLN GLY MET MET ALA PHE ALA GLU HIS PRO SEQRES 22 A 418 ASP GLN TRP GLU LEU TYR LYS LYS VAL ARG PRO GLU THR SEQRES 23 A 418 ALA ALA ASP GLU ILE VAL ARG TRP ALA THR PRO VAL THR SEQRES 24 A 418 ALA PHE GLN ARG THR ALA LEU ARG ASP TYR GLU LEU SER SEQRES 25 A 418 GLY VAL GLN ILE LYS LYS GLY GLN ARG VAL VAL MET PHE SEQRES 26 A 418 TYR ARG SER ALA ASN PHE ASP GLU GLU VAL PHE GLN ASP SEQRES 27 A 418 PRO PHE THR PHE ASN ILE LEU ARG ASN PRO ASN PRO HIS SEQRES 28 A 418 VAL GLY PHE GLY GLY THR GLY ALA HIS TYR CYS ILE GLY SEQRES 29 A 418 ALA ASN LEU ALA ARG MET THR ILE ASN LEU ILE PHE ASN SEQRES 30 A 418 ALA VAL ALA ASP HIS MET PRO ASP LEU LYS PRO ILE SER SEQRES 31 A 418 ALA PRO GLU ARG LEU ARG SER GLY TRP LEU ASN GLY ILE SEQRES 32 A 418 LYS HIS TRP GLN VAL ASP TYR THR GLY ARG CYS PRO VAL SEQRES 33 A 418 ALA HIS SEQRES 1 B 418 ASN GLY PRO SER PRO ASN LEU PRO PRO GLY PHE ASP PHE SEQRES 2 B 418 THR ASP PRO ALA ILE TYR ALA GLU ARG LEU PRO VAL ALA SEQRES 3 B 418 GLU PHE ALA GLU LEU ARG SER ALA ALA PRO ILE TRP TRP SEQRES 4 B 418 ASN GLY GLN ASP PRO GLY LYS GLY GLY GLY PHE HIS ASP SEQRES 5 B 418 GLY GLY PHE TRP ALA ILE THR LYS LEU ASN ASP VAL LYS SEQRES 6 B 418 GLU ILE SER ARG HIS SER ASP VAL PHE SER SER TYR GLU SEQRES 7 B 418 ASN GLY VAL ILE PRO ARG PHE LYS ASN ASP ILE ALA ARG SEQRES 8 B 418 GLU ASP ILE GLU VAL GLN ARG PHE VAL MET LEU ASN MET SEQRES 9 B 418 ASP ALA PRO HIS HIS THR ARG LEU ARG LYS ILE ILE SER SEQRES 10 B 418 ARG GLY PHE THR PRO ARG ALA VAL GLY ARG LEU HIS ASP SEQRES 11 B 418 GLU LEU GLN GLU ARG ALA GLN LYS ILE ALA ALA GLU ALA SEQRES 12 B 418 ALA ALA ALA GLY SER GLY ASP PHE VAL GLU GLN VAL SER SEQRES 13 B 418 CYS GLU LEU PRO LEU GLN ALA ILE ALA GLY LEU LEU GLY SEQRES 14 B 418 VAL PRO GLN GLU ASP ARG GLY LYS LEU PHE HIS TRP SER SEQRES 15 B 418 ASN GLU MET THR GLY ASN GLU ASP PRO GLU TYR ALA HIS SEQRES 16 B 418 ILE ASP PRO LYS ALA SER SER ALA GLU LEU ILE GLY TYR SEQRES 17 B 418 ALA MET LYS MET ALA GLU GLU LYS ALA LYS ASN PRO ALA SEQRES 18 B 418 ASP ASP ILE VAL THR GLN LEU ILE GLN ALA ASP ILE ASP SEQRES 19 B 418 GLY GLU LYS LEU SER ASP ASP GLU PHE GLY PHE PHE VAL SEQRES 20 B 418 VAL MET LEU ALA VAL ALA GLY ASN GLU THR THR ARG ASN SEQRES 21 B 418 SER ILE THR GLN GLY MET MET ALA PHE ALA GLU HIS PRO SEQRES 22 B 418 ASP GLN TRP GLU LEU TYR LYS LYS VAL ARG PRO GLU THR SEQRES 23 B 418 ALA ALA ASP GLU ILE VAL ARG TRP ALA THR PRO VAL THR SEQRES 24 B 418 ALA PHE GLN ARG THR ALA LEU ARG ASP TYR GLU LEU SER SEQRES 25 B 418 GLY VAL GLN ILE LYS LYS GLY GLN ARG VAL VAL MET PHE SEQRES 26 B 418 TYR ARG SER ALA ASN PHE ASP GLU GLU VAL PHE GLN ASP SEQRES 27 B 418 PRO PHE THR PHE ASN ILE LEU ARG ASN PRO ASN PRO HIS SEQRES 28 B 418 VAL GLY PHE GLY GLY THR GLY ALA HIS TYR CYS ILE GLY SEQRES 29 B 418 ALA ASN LEU ALA ARG MET THR ILE ASN LEU ILE PHE ASN SEQRES 30 B 418 ALA VAL ALA ASP HIS MET PRO ASP LEU LYS PRO ILE SER SEQRES 31 B 418 ALA PRO GLU ARG LEU ARG SER GLY TRP LEU ASN GLY ILE SEQRES 32 B 418 LYS HIS TRP GLN VAL ASP TYR THR GLY ARG CYS PRO VAL SEQRES 33 B 418 ALA HIS HET HEM A 501 43 HET JUR A 502 26 HET SO4 A 503 5 HET SO4 A 504 5 HET CL A 505 1 HET CL A 506 1 HET CL A 507 1 HET HEM B 501 43 HET JUR B 502 26 HET SO4 B 503 5 HET SO4 B 504 5 HET SO4 B 505 5 HET CL B 506 1 HETNAM HEM PROTOPORPHYRIN IX CONTAINING FE HETNAM JUR 1-(2-PIPERAZIN-1-YLETHYL)-5-PYRIDIN-4-YL-INDOLE-2- HETNAM 2 JUR CARBOXAMIDE HETNAM SO4 SULFATE ION HETNAM CL CHLORIDE ION HETSYN HEM HEME FORMUL 3 HEM 2(C34 H32 FE N4 O4) FORMUL 4 JUR 2(C20 H23 N5 O) FORMUL 5 SO4 5(O4 S 2-) FORMUL 7 CL 4(CL 1-) FORMUL 16 HOH *299(H2 O) HELIX 1 AA1 ASP A 30 ALA A 35 1 6 HELIX 2 AA2 PRO A 39 ALA A 50 1 12 HELIX 3 AA3 LYS A 75 HIS A 85 1 11 HELIX 4 AA4 ALA A 105 VAL A 111 1 7 HELIX 5 AA5 GLN A 112 MET A 119 5 8 HELIX 6 AA6 PRO A 122 SER A 132 1 11 HELIX 7 AA7 ARG A 133 PHE A 135 5 3 HELIX 8 AA8 THR A 136 ARG A 142 1 7 HELIX 9 AA9 LEU A 143 GLY A 162 1 20 HELIX 10 AB1 PHE A 166 VAL A 170 1 5 HELIX 11 AB2 CYS A 172 GLY A 184 1 13 HELIX 12 AB3 PRO A 186 MET A 200 1 15 HELIX 13 AB4 ASP A 205 ALA A 209 5 5 HELIX 14 AB5 ASP A 212 ASN A 234 1 23 HELIX 15 AB6 ASP A 238 ILE A 244 1 7 HELIX 16 AB7 SER A 254 GLY A 269 1 16 HELIX 17 AB8 ASN A 270 HIS A 287 1 18 HELIX 18 AB9 HIS A 287 ARG A 298 1 12 HELIX 19 AC1 THR A 301 THR A 311 1 11 HELIX 20 AC2 TYR A 341 ASN A 345 1 5 HELIX 21 AC3 GLY A 379 MET A 398 1 20 HELIX 22 AC4 ASP B 30 ALA B 35 1 6 HELIX 23 AC5 PRO B 39 ALA B 50 1 12 HELIX 24 AC6 LYS B 75 HIS B 85 1 11 HELIX 25 AC7 ALA B 105 VAL B 111 1 7 HELIX 26 AC8 GLN B 112 MET B 119 5 8 HELIX 27 AC9 PRO B 122 SER B 132 1 11 HELIX 28 AD1 ARG B 133 PHE B 135 5 3 HELIX 29 AD2 THR B 136 LEU B 143 1 8 HELIX 30 AD3 LEU B 143 GLY B 162 1 20 HELIX 31 AD4 PHE B 166 VAL B 170 1 5 HELIX 32 AD5 CYS B 172 GLY B 184 1 13 HELIX 33 AD6 PRO B 186 GLU B 188 5 3 HELIX 34 AD7 ASP B 189 MET B 200 1 12 HELIX 35 AD8 ASP B 205 ALA B 209 5 5 HELIX 36 AD9 ASP B 212 ASN B 234 1 23 HELIX 37 AE1 ASP B 238 GLN B 245 1 8 HELIX 38 AE2 SER B 254 GLY B 269 1 16 HELIX 39 AE3 ASN B 270 HIS B 287 1 18 HELIX 40 AE4 HIS B 287 ARG B 298 1 12 HELIX 41 AE5 THR B 301 THR B 311 1 11 HELIX 42 AE6 TYR B 341 ASN B 345 1 5 HELIX 43 AE7 ASP B 347 GLN B 352 1 6 HELIX 44 AE8 GLY B 379 MET B 398 1 20 SHEET 1 AA1 5 ILE A 52 GLY A 56 0 SHEET 2 AA1 5 GLY A 69 ILE A 73 -1 O PHE A 70 N ASN A 55 SHEET 3 AA1 5 ARG A 336 PHE A 340 1 O VAL A 338 N TRP A 71 SHEET 4 AA1 5 ALA A 315 ALA A 320 -1 N ARG A 318 O VAL A 337 SHEET 5 AA1 5 PHE A 89 SER A 90 -1 N SER A 90 O THR A 319 SHEET 1 AA2 3 SER A 163 ASP A 165 0 SHEET 2 AA2 3 GLN A 422 ASP A 424 -1 O VAL A 423 N GLY A 164 SHEET 3 AA2 3 LYS A 402 PRO A 403 -1 N LYS A 402 O ASP A 424 SHEET 1 AA3 2 TYR A 324 LEU A 326 0 SHEET 2 AA3 2 VAL A 329 ILE A 331 -1 O VAL A 329 N LEU A 326 SHEET 1 AA4 2 GLU A 408 ARG A 409 0 SHEET 2 AA4 2 ILE A 418 HIS A 420 -1 O HIS A 420 N GLU A 408 SHEET 1 AA5 5 ILE B 52 GLY B 56 0 SHEET 2 AA5 5 GLY B 69 ILE B 73 -1 O PHE B 70 N ASN B 55 SHEET 3 AA5 5 ARG B 336 PHE B 340 1 O VAL B 338 N TRP B 71 SHEET 4 AA5 5 ALA B 315 ALA B 320 -1 N PHE B 316 O MET B 339 SHEET 5 AA5 5 PHE B 89 SER B 90 -1 N SER B 90 O THR B 319 SHEET 1 AA6 3 SER B 163 ASP B 165 0 SHEET 2 AA6 3 GLN B 422 ASP B 424 -1 O VAL B 423 N GLY B 164 SHEET 3 AA6 3 LYS B 402 PRO B 403 -1 N LYS B 402 O ASP B 424 SHEET 1 AA7 2 TYR B 324 LEU B 326 0 SHEET 2 AA7 2 VAL B 329 ILE B 331 -1 O VAL B 329 N LEU B 326 SHEET 1 AA8 2 GLU B 408 ARG B 409 0 SHEET 2 AA8 2 ILE B 418 HIS B 420 -1 O LYS B 419 N GLU B 408 LINK SG CYS A 377 FE HEM A 501 1555 1555 2.47 LINK FE HEM A 501 N12 JUR A 502 1555 1555 2.53 LINK SG CYS B 377 FE HEM B 501 1555 1555 2.39 LINK FE HEM B 501 N12 JUR B 502 1555 1555 2.40 CISPEP 1 ALA A 121 PRO A 122 0 2.37 CISPEP 2 ASN A 362 PRO A 363 0 -0.66 CISPEP 3 ALA B 121 PRO B 122 0 0.93 CISPEP 4 ASN B 362 PRO B 363 0 2.07 CRYST1 67.808 90.096 152.873 90.00 90.00 90.00 P 21 21 21 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.014748 0.000000 0.000000 0.00000 SCALE2 0.000000 0.011099 0.000000 0.00000 SCALE3 0.000000 0.000000 0.006541 0.00000